Histoplasmosis y bacteremia persistente por Staphylococcus aureus meticilino-resistente asociada a derivación ventriculoperitoneal: reporte de caso

Autor: Carolina Álvarez-Ortega

Publikováno v: Infectio, Vol 28, Iss 2, Pp 130-134 (2024)

La histoplasmosis es una infección fúngica causada por Histoplasma ssp, que afecta principalmente el sistema respiratorio, mientras que Staphylococcus aureusresistente a la meticilina (SARM) es una bacteria notoria por ser resistente a los antibió

Externí odkaz: https://doaj.org/article/f6dcd6fe1aad4c4a8ca48ad58bb62f37

Differences Between Methicillin-susceptible Versus Methicillin-resistant Staphylococcus aureus Infections in Pediatrics

Autor: Beltrán-Higuera, Sandra Jaqueline, Palacios-Ariza, María Alejandra, Mancera-Gutiérrez, Luz Angela, Velandia-Páez, Jessica Paola, Camacho-Moreno, Germán, Ortiz-Mendez, Cesar Alfredo, Rojas-Rojas, Diana Paola, Romero-Higuera, Laura Natalia, Gómez-Cortés, Leydi Cristina, Vásquez-Hoyos, Pablo, Sosa-Rodríguez, Yeni Andrea, Brand-López, Katherine, Gutiérrez, Iván Felipe, Camacho-Cruz, Jhon, Wilches Cuadros, María Angélica, Hernandez-Vargas, Juan Camilo

Publikováno v: Magill SS, O’Leary E, Janelle SJ, et al; Emerging Infections Program Hospital Prevalence Survey Team. Changes in prevalence of health careassociated infections in U.S. hospitals. N Engl J Med. 2018;379:1732–1744.
Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
Zervou FN, Zacharioudakis IM, Ziakas PD, et al. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133:e1015–e1023.
Senthilkumar K, Biswal N, Sistla S. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children. Indian Pediatr. 2015;52:31–33.
David MZ, Daum RS. Update on epidemiology and treatment of MRSA infections in children. Curr Pediatr Rep. 2013;1:170–181.
Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49:65–71.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net)-Annual Epidemiological Report 2019. Stockholm: ECDC; 2020. Available at: https://www.ecdc.europa. eu/sites/default/files/documents/surveillance-antimicrobial-resistanceEurope-2019.pdf. Accessed November 30, 2020.
Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016;137:e20153099.
Song X, Cogen J, Singh N. Incidence of methicillin-resistant Staphylococcus aureus infection in a children’s hospital in the Washington metropolitan area of the United States, 2003-2010. Emerg microbes & infect. 2013;2:e69.
Sáenz Moncaleano V. Boletín Informativo: resultados de la vigilancia de la resistencia bacteriana Año 2018 componente pediátrico y adulto. Universidad Nacional de Colombia; 2018:26.
Márquez-Ortiz RA, Álvarez-Olmos MI, Escobar Pérez JA, et al; Research Group of Pediatric Infectious Diseases. USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children. Int J Infect Dis. 2014;25:88–93.
Rojo P, Barrios M, Palacios A, et al. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8:541–554.
John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatr Clin North Am. 2006;53:699–713.
Mejer N, Westh H, Schonheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC infectious diseases. 2012;12:260
Klieger SB, Vendetti ND, Fisher BT, et al. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36:603–605.
Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910–917.
Davis WT, Gilbert SR. Comparison of methicillin-resistant versus Susceptible Staphylococcus aureus pediatric osteomyelitis. J Pediatr Orthop. 2018;38:e285–e291.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Antecedentes: La epidemiología de Staphylococcus aureus resistente a la meticilina (MRSA) y S. aureus sensible a la meticilina (MSSA) ha cambiado en los últimos años. El presente artículo tiene como objetivo establecer las diferencias entre los h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bbf5ea7eb38df6d63eddeeba4ea435f
https://repository.urosario.edu.co/handle/10336/37949

Incidencia y distribución estacional de Staphylococcus aureus resistente a la meticilina en pacientes adultos ambulatorios en una clínica de la provincia de Buenos Aires: período 2006 - 2011 Incidence and seasonal distribution of methicillin-resistant Staphylococcus aureus in adult outpatients as a clinic in Buenos Aires province: period 2006 to 2011

Autor: María T Verón, María G Ojeda, Fabián Avino, Anabella Spelzini, Ana L Barboza, Yesica Petrozzino

Publikováno v: Revista Argentina de Microbiología, Vol 44, Iss 4, Pp 306-311 (2012)

En la última década aumentaron los aislamientos de Staphylococcus aureus resistente a la meticilina adquiridos en la comunidad (SAR M-AC ). Se describe la incidencia anual, distribución estacional, resistencia a los antimicrobianos y fenotipos de

Externí odkaz: https://doaj.org/article/eb0a5fcbc9934162a80d43a88de26530

Resistencia de Staphylococcus aureus a los antibióticos en un hospital de la orinoquia colombiana Antimicrobial resistance of Staphylococus aureus at a hospital from the Colombian Orinoquia

Autor: Norton Pérez, Norma Pavas, Emma Isabel Rodríguez

Publikováno v: Infectio, Vol 14, Iss 3, Pp 167-173 (2010)

Introducción: El objetivo de este estudio de cohorte retrospectivo fue analizar la resistencia de Staphylococcus aureus a los antibióticos en el Hospital Departamental de Villavicencio, centro de mediana y alta complejidad, entre 2005 y 2009. Mater

Externí odkaz: https://doaj.org/article/4d1a14e108a74a748c418f8259e8ead7

Experience of the use of Ceftaroline in a fourth level hospital in Colombia: Characterization and outcomes of the cohort between 2015-2020

Autor: Millán Prada, Henry Augusto

Publikováno v: Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 2013;19(6):492-500
Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG, Hellmich M, Hopkins S, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect. 2014;68(3):242–51
Moise PA, Schentag JJ: Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int J Antimicrob Agents. 2000;16 Suppl 1:S31-4
Silverman JA, Mortin LI, Vanpraagh AD, Li T, Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact: J. Infect. Dis. 2005;191(12):2149-52
Corey GR, Wilcox M, Talbot GH, Friedland HD, Baculik T, Witherell GW, et al. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, doubleblind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis. 2010;15(6):641–50
Mariani PG, Sader HS, Jones RN: Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. J. Antimicrob. Chemother. 2006;58(2):481–83
Zhong NS, Sun T, D’Souza G, Lee SH, Lan NH, Chiang CH, et al. Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with communityacquired pneumonia: a randomised, controlled, double-blind, phase 3, noninferiority with nested superiority trial. Lancet Infect Dis. 2015;15(2):161-71
J Horcajada et al. Ceftaroline, a new broad-spectrum cephalosporin in the era of multiresistance. Enferm Infecc Microbiol Clin. 2014;32(Supl 2):1-7.
Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R; National Nosocomial Infections. Surveillance System. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42(3):389-91
Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA. 2009;301(7):727-36
Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillinresistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5(5):275-86
Vandenesch F, Naimi T, Enright MC, et al. Community acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9(8):978-84.
Casadevall A. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? Fungal Genetics and Biology. 2005;42(2):98–106.
Soliman MS, Soliman NS, El-Manakhly AR, ElBanna SA, Aziz RK, El-Kholy AA. Genomic characterization of methicillin-resistant Staphylococcus aureus (MRSA) by high-throughput sequencing in a tertiary care hospital. Genes (Basel). 2020;11(10):1219
Bassetti M, Russo A, Cilloniz C, Giacobbe DR, Vena A, Amaro R, et al. Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain. Int J Antimicrob Agents. 2020;55(4):105921.
Pani A, Colombo F, Agnelli F, Frantellizzi V, Baratta F, Pastori D, et al. Off-label use of ceftaroline fosamil: A systematic review. Int J Antimicrob Agents. 2019;54(5):562–71.
Hernández F. Cost-effectiveness of ceftolozane/ tazobactam for the treatment of complicated intraabdominal and urinary tract infections in Colombia. Infectio. 2020;24(1).
2011 Sesión extraordinaria presencial 15 de noviembre. Instituto Nacional de Vigilancia de Medicamentos y Alimentos – INVIMA; Comisión revisora sala especializada de medicamentos y productos biológicos, Acta 53. 2011.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Las infecciones por especies de Staphylococcus Resistente a la Meticilina (SAMR) son un problema importante en el contexto hospitalario y cada vez más frecuente en la comunidad. En la actualidad las alternativas para el manejo de dichas infecciones,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e535fd29b17c6d10d47d7e15a21076